Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis
International Immunopharmacology · 2024-09 · 139 · 112703
DOI: 10.1016/j.intimp.2024.112703 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-09. Verfasst von Yuxun Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key…. Hauptthemen laut MEDLINE: Minocycline, Retinitis Pigmentosa, Mitochondria, Homeostasis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sun Yat-sen University.
Abstract (Originalsprache)
Minocycline, a broad-spectrum tetracycline antibiotic, has been shown to possess anti-inflammatory and antioxidative effects in various neurodegenerative diseases. However, its specific effects on retinitis pigmentosa (RP) have not been thoroughly investigated. Therefore, the objective of this study was to explore the potential role of minocycline in treating RP. In this investigation, we used rd1 to explore the antioxidant effect of minocycline in RP. Minocycline therapy effectively restored retinal function and structure in rd1 mice at 14 days postnatal. Additionally, minocycline inhibited the activation of microglia. Moreover, RNA sequencing analysis revealed a significant downregulation in the expression of mitochondrial genes within the retina of rd1 mice. Further KEGG and GO pathway analysis indicated impaired oxidative phosphorylation and electron transport chain processes. TEM confirmed the presence of damaged mitochondria in photoreceptors, while JC-1 staining demonstrated a decrease in mitochondrial membrane potential, accompanied by an increase in mitochondrial reactive oxygen species (ROS) levels. However, treatment with minocycline successfully reversed the abnormal expression of mitochondrial genes and reduced the levels of mitochondrial ROS, thereby providing protection against photoreceptor degeneration. Collectively, minocycline demonstrated the ability to rescue photoreceptor cells in RP by effectively modulating mitochondrial homeostasis and subsequently inflammation. These findings hold significant implications for the development of potential therapeutic strategies for RP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial…
Förderung
- National Natural Science Foundation of China
- Sun Yat-sen University
Zitieren
APA
Shi, Y., Chen, Y., Pan, Y., Chen, G., Xiao, Z., Chen, X., Wang, M., & Liang, D. (2024). Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis. International Immunopharmacology, 139, 112703. https://doi.org/10.1016/j.intimp.2024.112703
Vancouver
Shi Y, Chen Y, Pan Y, Chen G, Xiao Z, Chen X, et al. Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis. International Immunopharmacology. 2024;139:112703. doi:10.1016/j.intimp.2024.112703
BibTeX
@article{Shi2024,
author = {Shi, Yuxun and Chen, Yuxi and Pan, Yuan and Chen, Guanyu and Xiao, Zhiqiang and Chen, Xiaoqing and Wang, Minzhen and Liang, Dan},
title = {Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis},
journal = {International Immunopharmacology},
year = {2024},
volume = {139},
pages = {112703},
doi = {10.1016/j.intimp.2024.112703}
}
EUVIMED